Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Deal Gives Vividion Small Molecule War Chest

BIOTECH: Co. to Take on Previously ‘Undruggable’ ProteinsEven by startup standards, Vividion Therapeutics CEO Diego Miralles makes bold claims. He said the venture marks a “once-in-a-generation opportunity” to build a transformative company in San Diego.

Luna DNA Adds to Leadership Team, Sets Up in Solana Beach

Luna DNA, a startup led by former Illumina executives, has filled out its leadership roster.

Toft Group Hires COO

Ronald Giannotti has been appointed as COO of Toft Group Executive Search, a San Diego-based firm centered on executive searches in life sciences and health care.

Tease photo

Human Longevity Taps Scott Sorensen as CTO

San Diego’s Human Longevity, Inc. has named Scott Sorensen chief technology officer as the company brings its genomics and health program to more locations globally.

Heron Therapeutics’ Stock Rises on Data for Opioid Alternative Anesthetic

A Heron Therapeutics postoperative pain anesthetic billed as an alternative to opioids achieved positive late-stage trial results, boosting the San Diego company’s stock.

Twist Bioscience Opens Carlsbad Office

San Francisco-based Twist Bioscience Corporation has opened a 2,500-square-foot office in Carlsbad.

Making Machines Work for Co., Clinic

BIOTECH: Illumina SVP Tackles Challenges

Susan Tousi doesn’t practice medicine, unlike many in her family tree. But Illumina’s senior vice president of product development is making her mark on health.

Tease photo

Daré Bioscience Enters into Development Agreement

Daré Bioscience, a San Diego biopharmaceutical focused on women’s reproductive health, has partnered with Orbis Biosciences to develop long-lasting injectable contraceptives.

Ionis Spinout to Commercialize Inotersen

Carlsbad’s Ionis Pharmaceuticals is entrusting Akcea Therapeutics, a spinout of Ionis, to commercialize the drug inotersen ahead of a showdown.

Drug Salvage Operation May Be Salvation for Cancer Victims

John Hood turned a cast-off drug into a multibillion deal.

Tease photo

Edico Takes Big Step Into Medical Records

BIOTECH: Partnership to Put Genomics Data in Files

San Diego’s Edico Genome recently inked a deal to incorporate genomics data into electronic medical records, a cutting-edge space for which the company appears to be well positioned.

Tease photo

Crinetics Pharmaceuticals Raises $63.5 Million in Series B Round

San Diego biotech Crinetics Pharmaceuticals, taking aim at endocrine-related cancers and endocrine disorders, raised $63.5 million through a Series B financing round.

Bankruptcy Sale on Tap for Orexigen Therapeutics

Orexigen’s weight-loss prescription drug, Contrave, didn’t meet sales expectations, running afoul of an agreement with creditors, according to court documents.

Platform to Build Big Picture With Diverse Data

BIOTECH: Customer Controls Info, Can Contribute to Research

Between 23andMe, the omnipresent Fitbit and the electronic medical records created with each doctor’s visit, quantifying our health has become mainstream.

Tease photo

Alphatec Raises $50 Million, Acquires SafeOp

In a flurry of moves announced this week, Alphatec acquired SafeOp Surgical, raised $50 million and installed Patrick Miles as CEO.